Sodium-Glucose Cotransporter-2 Inhibitors as Enablers of Chronic Glucocorticoid Therapy
Author links open overlay panel Rami Kahwash MD a, Javed Butler MD, MPH, MBA b
Author links open overlay panel Rami Kahwash MD a, Javed Butler MD, MPH, MBA b
Für den erfolg reichen Abschluss der Fortbildungsmodule ist die korrekte (mind. 70%) Beantwortung der Lernerfolgskontrolle für das jeweilige Modul verpflichtend. Jetzt gleich den Fragebogen ausfüllen!…
Without effective treatment, pulmonary arterial hypertension results in high morbidity and mortality. This review discusses the pathogenesis of the disorder, the thorough clinical evaluation requir…
Stereotactic body radiotherapy (SBRT) has firmly established its role in stage I non-small cell lung cancer (NSCLC). Clinical trial results may not fully apply to…
Maxwell et al. show that ARID1A loss enhances antitumor immunity by triggering a type I IFN response through the cGAS–STING pathway, thereby promoting T cell…
An abstract is unavailable.
This is a clip taken from the Live-stream held on Physics Girl for the Open Medicine Foundation. Kyle was lucky enough to speak with Dr.…
Isocitrate dehydrogenase 1 (IDH1) is the most commonly mutated metabolic gene across human cancers. Mutant IDH1 (mIDH1) generates the oncometabolite (R)-2-hydroxyglutarate, disrupting enzymes involved in…
Show This Week in Cardiology, Ep Jul 26, 2024 This Week in Cardiology Podcast – Jul 26, 2024
Cancer survivorship starts at diagnosis, requiring support for patient and families to maximize quality of life before, during and after treatment.